radioimmunotherapy

RADIATION4 trials

Sponsors

Fred Hutchinson Cancer Center, University Hospital Tuebingen, AIDS Malignancy Consortium, Yanhong Deng

Conditions

AIDS-related LymphomaAdult Non-Hodgkin's LymphomaAnaplastic Large Cell LymphomaLeukemiaNon-Hodgkin LymphomaRectal Cancer

Phase 1

Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma

CompletedNCT00302757

University Hospital TuebingenNon-Hodgkin Lymphoma

Start: 2006-03-31End: 2011-07-31Target: 60Updated: 2014-05-29

Phase 2

Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

CompletedNCT00002554

Fred Hutchinson Cancer CenterLeukemia

Start: 1993-11-30End: 1999-12-31Target: 30Updated: 2010-03-30

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

WithdrawnNCT00310128

AIDS Malignancy ConsortiumAdult Non-Hodgkin's Lymphoma, AIDS-related Lymphoma, Anaplastic Large Cell Lymphoma

Start: 2006-02-28Updated: 2016-02-03

Unknown Phase

Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer

CompletedNCT06898359

Yanhong DengRectal Cancer

Start: 2022-05-20End: 2023-08-28Updated: 2025-03-27

Related Papers

Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphoma.

2012-04-1614 citations

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.

2010-06-0741 citations